There are several kinds of bias that may occur in clinical trials, including selection, measurement, and publication bias. Statistics are used in clinical trials in order to avoid or...
Some groups within the general population of a clinical study may require special study, due to the particular risks, benefits, or treatment requirements associated with them
This article explores patient involvement in scientific regulatory committees in the EU, specifically in the activities of the European Medicines Association (EMA).
In Phase II trials, the investigational medicinal product is tested for efficacy (and safety). The studies conducted are typically therapeutic exploratory studies which try to discover whether the medicine...
Participant adherence is an essential part of every clinical trial and means ‘the extent to which participants follow the instructions they have been given for participating in the clinical...
Inclusion of a patient expert on a pharmaceutical company’s external Bioethics Advisory Panel. The patient expert was proposed to the existing panel so a patient view would be included...
